Ligand Pharmaceuticals
LGND
#3601
Rank
NZ$6.29 B
Marketcap
NZ$320.01
Share price
-1.93%
Change (1 day)
52.41%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.91 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.19 B44.66%
2023-12-31NZ$0.13 B-47.55%
2022-12-31NZ$0.26 B-62.7%
2021-12-31NZ$0.69 B-22.9%
2020-12-31NZ$0.90 B-16.27%
2019-12-31NZ$1.08 B3.55%
2018-12-31NZ$1.04 B193.62%
2017-12-31NZ$0.35 B6.68%
2016-12-31NZ$0.33 B0.81%
2015-12-31NZ$0.33 B10.82%
2014-12-31NZ$0.29 B344.69%
2013-12-31NZ$67.05 M-29.08%
2012-12-31NZ$94.54 M-34.35%
2011-12-31NZ$0.14 B38.18%
2010-12-31NZ$0.10 B-45.17%
2009-12-31NZ$0.19 B-39.33%
2008-12-31NZ$0.31 B66.47%
2007-12-31NZ$0.18 B-55.61%
2006-12-31NZ$0.42 B-31.82%
2005-12-31NZ$0.62 B8.81%
2004-12-31NZ$0.57 B5.66%
2003-12-31NZ$0.54 B40.54%
2002-12-31NZ$0.38 B-8.86%
2001-12-31NZ$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
NZ$139.38 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$0.13 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.08 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$134.39 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.16 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$157.66 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.51 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$23.97 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.53 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA